Q-omics provides the consensus-scored RNU2-31P profile across patient tissues and cancer cell-line models. RNU2-31P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU2-31P RNA expression shows 12,645 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight BLCA, and LSCC as cancer lineages where RNU2-31P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.